Pharmaceutical microbiology: key developments 2022
European Pharmaceutical Review
JANUARY 16, 2023
The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” The previous record for vaccine development and approval was four years for the measles vaccine.
Let's personalize your content